NLX-112, a highly selective 5-HT(1A) receptor biased agonist, does not exhibit misuse potential in male rats or macaques.
- DOI
- 10.1016/j.neuropharm.2022.109025
- Published
- 2022 Jun 1
- Container
- Neuropharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuropharm.2022.109025,
title = {NLX-112, a highly selective 5-HT(1A) receptor biased agonist, does not exhibit misuse potential in male rats or macaques.},
author = {Depoortère R and Bergman J and Beardsley PM and Desai RI and Paronis CA and Walentiny DM and Varney MA and Newman-Tancredi A},
year = {2022},
journal = {Neuropharmacology},
doi = {10.1016/j.neuropharm.2022.109025},
url = {https://doi.org/10.1016/j.neuropharm.2022.109025}
}RIS
TY - JOUR TI - NLX-112, a highly selective 5-HT(1A) receptor biased agonist, does not exhibit misuse potential in male rats or macaques. AU - Depoortère R AU - Bergman J AU - Beardsley PM AU - Desai RI AU - Paronis CA AU - Walentiny DM AU - Varney MA AU - Newman-Tancredi A PY - 2022 JO - Neuropharmacology DO - 10.1016/j.neuropharm.2022.109025 UR - https://doi.org/10.1016/j.neuropharm.2022.109025 ER -
APA
R, D., J, B., PM, B., RI, D., CA, P., DM, W., MA, V., & A, N. (2022). NLX-112, a highly selective 5-HT(1A) receptor biased agonist, does not exhibit misuse potential in male rats or macaques.. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2022.109025
Source records
- pubmed · retrieved 2026-09-27T12:21:11.902Z